Literature DB >> 15705439

COX-2 selective inhibitors--important lessons learned.

Simon R J Maxwell1, David J Webb.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15705439     DOI: 10.1016/S0140-6736(05)17876-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  A comparison of reported gastrointestinal and thromboembolic events between rofecoxib and celecoxib using observational data.

Authors:  Rachna Kasliwal; Deborah Layton; Scott Harris; Lynda Wilton; Saad A W Shakir
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland.

Authors:  D Williams; M Singh; C Hind
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

Review 3.  The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis.

Authors:  Liza Makowski; Gökhan S Hotamisligil
Journal:  Curr Opin Lipidol       Date:  2005-10       Impact factor: 4.776

Review 4.  Genomic medicine: genetic variation and its impact on the future of health care.

Authors:  Huntington F Willard; Misha Angrist; Geoffrey S Ginsburg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-08-29       Impact factor: 6.237

Review 5.  COX-2 inhibitors and the heart: are all coxibs the same?

Authors:  P Sooriakumaran
Journal:  Postgrad Med J       Date:  2006-04       Impact factor: 2.401

Review 6.  Selectivity of NSAIDs for COX-2 and cardiovascular outcome.

Authors:  S R J Maxwell; R A Payne; G D Murray; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

Review 7.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

Review 8.  Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.

Authors:  Brent Caldwell; Sarah Aldington; Mark Weatherall; Philippa Shirtcliffe; Richard Beasley
Journal:  J R Soc Med       Date:  2006-03       Impact factor: 18.000

9.  Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis.

Authors:  Gurkirpal Singh; Olivia Wu; Peter Langhorne; Rajan Madhok
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 10.  Turning liabilities into opportunities: Off-target based drug repurposing in cancer.

Authors:  Vinayak Palve; Yi Liao; Lily L Remsing Rix; Uwe Rix
Journal:  Semin Cancer Biol       Date:  2020-02-07       Impact factor: 15.707

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.